Introduction
In 1986, a new clinical disease in cattle was recognised in the United Kingdom (UK). It was classified as a progressive neurological condition similar to scrapie of sheep and goats, and was named bovine spongiform encephalopathy (BSE) (Wells et al. 1987) . Other transmissible spongiform encephalopathies (TSE) had been described before the occurrence of BSE, namely scrapie of sheep and goats (first observed/described as a clinical entity around 1730), a transmissible mink encephalopathy (TME, 1947) , a chronic wasting disease of North American deer and elk (CWD, 1978) , and the human TSEs sporadic CreutzfeldtJakob disease (sCJD, 1920) , Gerstmann-Sträus-sler-Scheinker Syndrom (GSS, 1928) , Kuru (1957) , and fatal familiar insomnia (FFI, 1986) . These TSEs can arise spontaneously (sCJD), be inherited (FFI, GSS), or are naturally or accidentally transmitted (scrapie, Kuru, CWD, BSE). Some of them possess several of these properties (Hartsough & Burger 1965 , Detwiler 1992 , Kimberlin 1992 , Williams & Young 1992 , Will 1993 , Hoinville 1996 , Spraker et al. 1997 , Prusiner 1998a . There is an ongoing discussion whether BSE should be classified as infectious, contagious, or zoonotic, and if it fits the definition of a production disease. The objective of this work is to briefly describe the main characteristics of TSEs, to review the epidemiology of BSE, and to address the question of how to classify BSE.
Characteristics of prion diseases
All known TSEs are characterised by an accumulation of prions ("proteinacious infectious particles", PrP) and vacuolation of the CNS in the final stages of the disease. PrP C is routinely synthesised by various cells, and is metabolised (digested) by proteinase K (enzymes). The infectious prion protein, denoted PrP Sc or PrP res , is partly proteinase K resistant. It forms oligomers, accumulates mainly in the cells of the CNS, and results in the specific histopathological changes observed in the differed TSEs (Prusiner 1998b) . Both PrP C and PrP Sc have the same aminoacid sequence, but they have different three-dimensional structures: PrP C in 42% is composed of structures called alpha helices, and has only a few beta sheets (Lopez Garcia et al. 2000) . The infectious PrP Sc has only 30% alpha helices, and more than 40% beta sheets. The transition of PrP C to PrP Sc , based on the prion dimer theory of Prusiner, occurs by merging of a normal (healthy) and an infectious prion molecule to form a PrP C -PrP Sc heterodimer, in which the normal PrP C molecule is restructured into PrP Sc . After separation of the 2 molecules, 2 new PrP Sc homodimers have been created which again can convert healthy PrP C molecules (Prusiner 1998b) . It still is debated whether PrP Sc and TSE infectivity are one and the same, or if there is an additional factor "X" (protein, virion, virus?) besides exposure to PrPSc required to result in a TSE infection (Telling et al. 1995) . TSE infectivity is difficult to destroy (decontaminate). The most efficient method is application of wet heat (autoclaving) after treatment with sodium hydroxide (1-2M NaOH). Application of dry heat will conserve TSE infectivity, and temperatures up to 600°C have been described as insufficient to fully eliminate it from brain tissue cubes (Brown et al. 1990 (Brown et al. , 2000 . The commonly used methods to treat MBM during rendering (133°C at 3 bars for 20 minutes) will reduce TSE infectivity by at least 98%, but not always by 100% (Taylor et al. 1998 , 1999 , Schreuder et al. 1998 , Taylor 1999 , 2000 . TSE infectivity, once excreted, can survive in the environment (soil) for several years, as has been demonstrated with the scrapie agent (Brown & Gajdusek 1991) .
Epidemiology of BSE
The origin of BSE (as a cattle disease) is an issue of controversial debate, but it is unlikely that this controversy will ever be resolved. The most widely accepted hypothesis is that cattle BSE originated from sheep scrapie, i.e. that one of the British sheep scrapie strains was recycled with MBM to cattle, and was (or became during recycling) infectious for cattle. After this adaptation, on-going intra-species recycling caused the BSE epidemic in British cattle (Schreuder 1993 , Taylor 1995 . Alternatively, a spontaneous mutation in the genome coding for the PrP gene, similar to sporadic CJD in humans, could have resulted in a TSE strain either in sheep or in cattle that was subsequently infectious for -and recycled to -cattle. The introduction of BSE from a wildlife population seems to be a less realistic hypothesis. Large scale recycling of BSE infectivity in the UK be-came possible after 1970 when changes in the tallow (fat) extraction during MBM rendering from solvent-based (wet, higher temperatures) to pressure-based (dry, lower temperatures) allowed the infectious agent to survive , Kimberlin 1992 . Epidemiological studies on the clinical BSE cases diagnosed in UK in 1986 and 1987 highlighted the increased risk for BSE on farms that had fed cattle concentrates containing meat and bone meal (MBM). The recycling of ruminantderived MBM to ruminants and other farm animals via concentrate feed was common practice in the UK and other countries ( Fig. 1) (Wilesmith et al. 1988 , 1992a , 1992b , Hoinville et al. 1995 , Anderson et al. 1996 . Cattle concentrates contained up to 6% protein of either animal or plant origin. As a consequence of the studies linking MBM use to BSE, this inclusion of MBM into ruminant feed was banned in the UK in July 1988, and in Switzerland in December 1990. These bans resulted in a significant reduction of new infections in cattle born after their implementation, thereby highlighting the importance of controlling this exposure route (Fig. 2) . The secondary increase in BSE cases by birth cohort seen in Switzerland might be the result of an increase in the number of infected cattle reaching clinical levels of disease, and increase of MBM imports from neighbouring European countries, and increase in the surveillance activities since 1999, or a combination of those factors. BSE cases born after these MBM bans (denoted BAB cases) documented the presence of other infection routes besides routine inclusion of MBM in cattle concentrates. Cross-contamination of cattle feed with feed for pigs and poultry during production, transportation or storage, and cross-exposure of cattle to pig or poultry feed on mixed-species farms were suggested as additional infection routes (Fig. 1 ) Figure 1 . BSE infection cycle and exposure of other species to products of cattle origin. Solid arrows (--)indicate direct exposure to cattle-derived products (cattle-derived food, cattle feed), broken arrows (-·-·) indicate exposure to feed produced for pigs or poultry, and dotted arrows (·····) indicate an exposure to feed produced for pets (dogs and cats). (Hoinville 1994 , Hoinville et al. 1995 . The Scientific Steering Committee (SSC) of the European Commission in a geographic BSE risk assessment exercise (GBR) listed several risk factors for BSE propagation (spread within a cattle population) including the structure and intensity of the cattle population and other livestock populations, production and use of ruminant-derived meat-and-bone meal (including feed bans), the use of specified risk material (SRM) and carcasses (including SRM bans) and the rendering industry (structure, technology, rendering parameters) (Alban et al. 2000 , SSC 2000a ). The most important measures to prevent exposure of cattle to BSE are the ban of feeding ruminant protein back to cattle ("MBM ban"), the exclusion of all high risk material such as brain and spinal cord of cattle and cattle carcasses from MBM production ("SRM ban"), the treatment of produced MBM at 133°C and 3 bars for 20 min (EU standard), and the prevention of cross contamination during feed production and use. Blocking of the known and suspected feed-related routes of BSE transmission has resulted in a documented decline in the number of new infections in subsequent birth cohorts in the UK, in Switzerland (Fig. 2) , and in other countries. Due to the long incubation time of BSE, however, it takes several years until the effectiveness of implemented measures to prevent new BSE infections can be reliably assessed.
Pathogenesis
Experimental oral inoculation of calves and sequential slaughter done in the UK documented that BSE infectivity was only present in the anatomical region of the Peyers patches of the distal ileum at distinct time points during the incubation period, and in the central nervous system (CNS: brain, spinal cord, dorsal root ganglia) late in incubation (few months before clinical disease) and during clinical disease. In cattle, BSE infectivity has not been docu- mented in meat, milk, blood, urine, lymph nodes or any other tissue besides the CNS and the distal ileum wall (Middleton & Barlow 1993 , Taylor et al. 1995 , Wells et al. 1994 , 1998 . One report in which sternal bone marrow isolated from a clinical BSE case in one of the experimentally exposed mice induced a TSE was never reproduced, and was later speculated to have been cross-contamination. Without excretion of the infectious agent during incubation or clinical disease, direct horizontal transmission (from infected to susceptible cattle) does not occur. BSE infectivity levels of CNS tissue from clinically diseased cattle have been titrated in cattle, and there is evidence that 0.1 gram of brain tissue is sufficient to orally infect calves with BSE. Direct intracerebral inoculation of the infectious agent into susceptible mice strains seems to be 500 to 1000 times more efficient than oral exposure of the mice, and this method is used extensively to study the distribution of BSE infectivity in various tissues of experimentally infected animals or field cases, and to differentiate between BSE and other TSE strains.
BSE spread and surveillance
Introduction of the BSE agent into recipient countries has occurred by live animal trade, and by direct or indirect trade between BSE-effected and BSE-free countries with MBM and other products potentially containing BSE in- fectivity (Hörnlimann et al. 1994 , Nathanson et al. 1997 , Schreuder et al. 1997 . The GBR done by the EU indicated a rather wide geographic distribution of the disease, and this has been confirmed by the surveillance activities implemented since the year 2000. Domestic BSE cases by now have been detected in all but one of the EU Member States (Sweden) as well as in Switzerland (Table 1 ). In addition, in 2001 Slovakia (4 cases), Japan (3), the Czech Republic (2) and Slovenia (1) experienced their first domestic BSE cases. Based on the GBR, additional countries such as Albania, Estonia, Hungary, Lithuania, Poland and Cyprus are expected to harbour BSE-infected cattle (SSC 2000a (SSC , 2001 ). BSE case detection until 1998 was restricted to the mandatory reporting and subsequent investigation of clinical suspect cases ("passive" surveillance). Since 1999 EU-validated fast screening assays such as the Prionics check Western blot or the BioRad Platelia ELISA have become available as a surveillance tool for targeted "high-risk" cohorts ("active" surveillance). This type of combined passive and active BSE surveillance was implemented in Switzerland in January of 1999, and is mandatory for the EU member states since January 1, 2001 (Doherr et al. 1999 , 2001 , 2002 , Schaller et al. 1999 , SSC 2000b , Schiermeier 2001 . Data from the Swiss surveillance indicated that mandatory suspect reporting captured less than 50% of the detectable BSE cases that were removed from the population (Doherr et al. 1999 (Doherr et al. , 2001 . In other countries passive surveillance might have completely missed a low number of clinical BSE cases for some periods of time. In recent years, however, an increase also in the number of clinical BSE cases was seen in continental Europe (Fig. 3 ) in addition to the cases detected by the passive surveillance. The combination of passive and active surveillance components therefore seem essential to reliably assess the BSE status of a given country or region. However, the EU-validated screening assays rely on the post mortem detection of PrP Sc in brain tissue (homogenate), and are validated only for cattle with clinical BSE (Moynagh & Schimmel 1999 , Schaller et al. 1999 , Oesch et al. 2000 , Deslys et al. 2001 . No BSE test is available for detection of animals during early incubation, and we have to assume that a considerable number of such cattle leaves the population undetected. Some ante mortem tests have been announced in the media, however, none has been commercialised so far.
Transmission of BSE to other species
Transmission of BSE to other species is possible. This has been documented in experimental infection of several species, but also in the observed FSE epidemic in domestic cats (over 90 cases in the UK reported since 1990), in ruminants and large cats kept in British zoos, and by the epidemic of the new variant of CreutzfeldtJakob disease (vCJD) in humans with over 100 cases in the UK and 4 cases reported from France so far , Wells & McGill 1992 , Schreuder 1994 , Collinge et al. 1996 , Will et al. 1996 , Hill et al. 1997 . BSE can be orally transmitted to sheep and goats where it results in a TSE very similar to scrapie (Foster et al. 1993 (Foster et al. , 1996 . No field cases of BSE in sheep have yet been diagnosed, however, differentiation to sheep scrapie is only possible by strain typing in mice bioassays, which takes several years to perform. Attempts to orally infect pigs or poultry with BSE failed so far (Dawson et al. 1990 , Done 1990 , Meldrum 1990 .
Conclusions
BSE is a new disease in cattle. Infectivity can be titrated, and the disease has been transmitted to the same and to other species including cats and humans. This classifies BSE as infectious and zoonotic. However, even cattle in the final stages of (clinical) disease do not actively excrete the infectious agent, and horizontal transmission comparable with that of foot-andmouth disease (FMD), classical swine fever (CSF) or even sheep scrapie does not occur; the disease therefore is not considered to be contagious. The term "production diseases" traditionally was used exclusively for metabolic diseases that were induced by management practices. More recently, the definition of production diseases has been widened to include other traits such as infertility, and multifactorial diseases such as mastitis and lameness that might involve infectious agents but that are exacerbated by nutritional or management factors (Nir Markusfeld 2001) . BSE, which is caused by an infectious agent (even though some "infectiologists" might not agree to classify prion diseases as such) and is dependent on management factors, would fit into the broader definition of production diseases. This, however, could be true for the majority of diseases that currently affect our animal production systems. 
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